Updated Oxford classification of IgA nephropathy: expanding scope of the schema

Muhammed Mubarak ¹ *

Cited by CrossRef: 3

1- Han S, Yao T, Lu Y, Chen M, Xu Y, Wang Y. Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis. Front Pharmacol. 2021;11 [Crossref]

2- Juan Y, Chiang W, Lin W, Yang C, Chou S, Hung R, Chiu Y. Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy. JCM. 2022;11(14):4231 [Crossref]

3- Zhao J, Wang J, Huang G, Feng C. Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children. 2021;100(21):e26050 [Crossref]